FdaApplication
NDA 216755
Identifiers
- fda_app_no: NDA216755
Properties
| Property | Value |
|---|---|
| applicant_name | SAPTALIS PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2023-09-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIKMEZ | METRONIDAZOLE | 500MG/5ML | SUSPENSION;ORAL |
1 product